Investing Profile

Johannes Zanzinger

InvestorVC

Investment Manager at Boehringer Ingelheim Venture Fund

Photo of Johannes Zanzinger, Investor at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$3.3M - $17.0M
$8.5M
2
CompanyStageDateRound SizeTotal Raised
Centauri Therapeutics
Series AFeb 2022£24M
£24M
Co-investors: Sebastian Kreuz (Boehringer Ingelheim Venture Fund)
DiogenX
Seed RoundJun 2020€4.5M
€4.5M
Co-investors: Katie Ellias (T1D Fund)